Literature DB >> 24928433

Fasting plasma glucose and incident heart failure risk: a population-based cohort study and new meta-analysis.

Hassan Khan1, Setor K Kunutsor2, Jussi Kauhanen3, Sudhir Kurl3, Eiran Z Gorodeski4, Amanda I Adler5, Javed Butler6, Jari A Laukkanen7.   

Abstract

BACKGROUND: There remains uncertainty regarding the association between fasting plasma glucose (FPG) and risk of heart failure (HF) in individuals without a history of diabetes. METHODS AND
RESULTS: We assessed the association between FPG and HF risk in a population-based cohort of 1,740 men aged 42-61 years who were free from HF or diabetes at baseline. During a mean follow-up of 20.4 years, 146 participants developed HF. In age-adjusted analysis, the hazard ratio (HR) for HF per 1 mmol/L increase in FPG was 1.34 (95% confidence interval 1.22-1.48). This association persisted after adjusting for established HF risk factors: HR 1.27, 95% confidence interval 1.14-1.42. The findings remained consistent across several clinical subgroups and in analyses excluding incident coronary heart disease or diabetes during follow-up. In a meta-analysis of 10 prospective studies involving 4,213 incident HF cases, the HR for HF per 1 mmol/L increase in FPG level was 1.11 (95% confidence interval 1.04-1.17), with evidence of heterogeneity between studies (I(2) = 79%; 95% confidence interval 63%-89%; P < .001). The corresponding HR was 1.12 (95% confidence interval 1.08-1.18) on exclusion of the single study that accounted for the heterogeneity.
CONCLUSIONS: There exists a positive, continuous, and independent association between FPG and risk for HF. Studies are warranted to evaluate the causal relevance of these findings.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fasting plasma glucose; diabetes; heart failure; meta-analysis; risk factor

Mesh:

Substances:

Year:  2014        PMID: 24928433     DOI: 10.1016/j.cardfail.2014.05.011

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  3 in total

1.  Reversing drug resistance of cisplatin by hsp90 inhibitors in human ovarian cancer cells.

Authors:  Zhengmao Zhang; Zhen Xie; Guangyu Sun; Pingfang Yang; Jia Li; Hongfang Yang; Shuang Xiao; Yang Liu; Hongbing Qiu; Lijun Qin; Chao Zhang; Fenghua Zhang; Baoen Shan
Journal:  Int J Clin Exp Med       Date:  2015-05-15

2.  Fasting glucose and insulin resistance trajectories during young adulthood and mid-life cardiac structure and function.

Authors:  Michael P Bancks; Mercedes R Carnethon; Lisa S Chow; Samuel S Gidding; David R Jacobs; Satoru Kishi; Joao Lima; Donald Lloyd-Jones; Jared P Reis; Pamela J Schreiner; Rachel Zmora; Norrina B Allen
Journal:  J Diabetes Complications       Date:  2019-02-06       Impact factor: 3.219

Review 3.  Risk for Incident Heart Failure: A Subject-Level Meta-Analysis From the Heart "OMics" in AGEing (HOMAGE) Study.

Authors:  Lotte Jacobs; Ljupcho Efremov; João Pedro Ferreira; Lutgarde Thijs; Wen-Yi Yang; Zhen-Yu Zhang; Roberto Latini; Serge Masson; Nera Agabiti; Peter Sever; Christian Delles; Naveed Sattar; Javed Butler; John G F Cleland; Tatiana Kuznetsova; Jan A Staessen; Faiez Zannad
Journal:  J Am Heart Assoc       Date:  2017-05-02       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.